HomeAI · summaries
Storia in 5 fonti
Why Is Vera Therapeutics Stock Gaining Tuesday? - Vera Therapeutics (NASDAQ:VERA)
Vera Therapeutics (VERA) stock jumps 9% following FDA accelerated approval for its kidney disease drug Trutakna. Full analysis here.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
What's Going on with Vera Therapeutics Stock on Monday? - Vera Therapeutics (NASDAQ:VERA)
Vera Therapeutics awaits the FDA's July 7 decision on atacicept for IgA nephropathy as investors weigh trial data and competition from Novartis.
- ·
healio.com
FDA approves Trutakna for proteinuria reduction in IgA nephropathy
The FDA granted accelerated approval to atacicept-vymj for proteinuria reduction in adults with primary immunoglobulin A nephropathy at risk for disease progression, according to…
